Hematology/Oncology

Top Story

Emotional distress may lead to unnecessary treatment for prostate cancer

Emotional distress may lead to unnecessary treatment for prostate cancer
February 20, 2017

Men with emotional distress after a prostate cancer diagnosis may be more likely to choose aggressive treatment, such as surgery rather than active surveillance, according to published findings.

“The good news is that there’s already a shift in the field toward being more concerned about cancer patients’ emotional well-being,” Heather Orom, PhD, assistant dean for equity, diversity and inclusion at the School of Public Health and Health Professions of University at Buffalo, told HemOnc Today. “What this study tells us is that we should be concerned about prostate cancer patients’ well-being from the point of diagnosis, not just after treatment.”

In the Journals Plus

Sorafenib benefit dependent on hepatitis status in patients with HCC

February 19, 2017
Sorafenib improved OS among patients with hepatocellular carcinoma who were hepatitis C positive but hepatitis B negative, suggesting that the beneficial effects of…
In the Journals Plus

High breast density, BMI greatest risk factors for breast cancer

February 18, 2017
Most breast cancers among premenopausal and postmenopausal women could be attributed to high breast density and BMI, according to results of a case–control study…
In the Journals

Medicaid expansions improved preventive care, but study finds Americans want changes to ACA

February 17, 2017
Due to insurance expansions of the Affordable Care Act, Americans were more likely to undertake preventive care, according to data published in Journal of Policy

Five articles that raise awareness about persistent clinical trial disparities

February 17, 2017
Clinical trials contribute to the overall understanding of cancer biology and help to advance treatment options and improve patient outcomes. However, gaps among…
More News Headlines »
CME

Hot Topics in Metastatic Breast Cancer Management: Clinical Advances with CDK4/6 Inhibitors

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

While the mortality rates for advanced or metastatic breast cancer (MBC) have steadily decreased, in part due to…
More »
Video
Meeting News

VIDEO: Glaser comments on the possible repeal of the ACA under Trump’s administration

January 16, 2017
More »
Featured
CME

Optimizing the Use of Targeted Therapy in Advanced Melanoma: Where We Are and Where We Are Going

This activity is supported by an educational grant from Genentech.

Melanoma is the deadliest form of skin cancer. Historically, treatment options have been limited for patients with…
More »
Current Issues
View the Current Issue
HemOnc Today
Advertisement
Advertisement